Literature DB >> 23123666

Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.

Hideki Yokoi1, Masato Kasahara, Kiyoshi Mori, Takashige Kuwabara, Naohiro Toda, Ryo Yamada, Shinji Namoto, Takashi Yamamoto, Nana Seki, Nozomi Souma, Taku Yamaguchi, Akira Sugawara, Masashi Mukoyama, Kazuwa Nakao.   

Abstract

Peritoneal dialysis (PD) solution contains high concentrations of glucose and glucose degradation products (GDPs). One of several GDPs--3,4-dideoxyglucosone-3-ene (3,4-DGE)--was recently identified as the most reactive and toxic GDP in PD fluids. In vitro, 3,4-DGE has been shown to induce mesothelial cell damage; however, its role in peritoneal fibrosis in vivo remains unclear. In the present study, we intraperitoneally administered chlorhexidine gluconate (CG) for mild peritoneal injury, and we then injected 3,4-DGE [38 μmol/L (low concentration) or 145 μmol/L (high concentration)] 5 times weekly for 4 weeks. Significant thickening of the parietal peritoneal membrane was observed only when treatment with low or high concentrations of 3,4-DGE occurred after CG administration, but not when either CG or 3,4-DGE alone was given. The combination of CG and 3,4-DGE also caused upregulation of messenger RNA expression of transforming growth factor β1, connective tissue growth factor, fibronectin, collagen type 1 α1 chain, alpha smooth muscle actin (α-SMA), vascular endothelial growth factor 164, NADPH oxidase 1 and 4, p22phox, p47phox, and gp91phox in peritoneal tissue. Treatment with CG alone was sufficient to cause significant F4/80-positive macrophage infiltration, appearance of α-SMA-positive cells, and vessel formation in the submesothelial layer. Addition of 3,4-DGE markedly enhanced those changes and induced apoptosis, mainly in leukocytes. The concentration of 3,4-DGE in the abdominal cavity declined more rapidly in CG-treated mice than in PBS-treated mice. Peritoneal membrane permeability determined by peritoneal equilibration test showed high transport conditions in peritoneum treated with both CG and 3,4-DGE. These results indicate that, when mild peritoneal damage is already present, 3,4-DGE causes peritoneal thickening and fibrosis, resulting in deterioration of peritoneal membrane function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123666      PMCID: PMC3598104          DOI: 10.3747/pdi.2011.00033

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  39 in total

1.  Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.

Authors:  Vedat Schwenger; Christian Morath; Alexander Salava; Kerstin Amann; Yuri Seregin; Reinhold Deppisch; Eberhard Ritz; Angelika Bierhaus; Peter P Nawroth; Martin Zeier
Journal:  J Am Soc Nephrol       Date:  2005-11-30       Impact factor: 10.121

2.  Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF.

Authors:  Joseph C K Leung; Loretta Y Y Chan; Felix F K Li; Sydney C W Tang; Kwok Wa Chan; Tak Mao Chan; Man Fai Lam; Anders Wieslander; Kar Neng Lai
Journal:  Nephrol Dial Transplant       Date:  2005-04-06       Impact factor: 5.992

3.  Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.

Authors:  Hideki Yokoi; Masato Kasahara; Kiyoshi Mori; Yoshihisa Ogawa; Takashige Kuwabara; Hirotaka Imamaki; Tomoko Kawanishi; Kenichi Koga; Akira Ishii; Yukiko Kato; Keita P Mori; Naohiro Toda; Shoko Ohno; Hisako Muramatsu; Takashi Muramatsu; Akira Sugawara; Masashi Mukoyama; Kazuwa Nakao
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

4.  Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.

Authors:  Mohammad Zareie; Geert-Jan Tangelder; Piet M ter Wee; Liesbeth H P Hekking; Anton A van Lambalgen; Eelco D Keuning; Inge L Schadee-Eestermans; Casper G Schalkwijk; Robert H J Beelen; Jacob van den Born
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

5.  Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane.

Authors:  H Noh; J S Kim; K-H Han; G T Lee; J S Song; S H Chung; J S Jeon; H Ha; H B Lee
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

6.  Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

Authors:  K Tanabe; Y Maeshima; K Ichinose; H Kitayama; Y Takazawa; K Hirokoshi; M Kinomura; H Sugiyama; H Makino
Journal:  Kidney Int       Date:  2006-12-27       Impact factor: 10.612

7.  Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.

Authors:  Siska Mortier; Dirk Faict; Norbert H Lameire; An S De Vriese
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

8.  Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.

Authors:  Chan-Duck Kim; Hyeog-Man Kwon; Sun-Hee Park; Eun-Joo Oh; Mi-Hyung Kim; Soon-Youn Choi; Min-Jeong Choi; In-San Kim; Min-Sun Park; Yong-Jin Kim; Yong-Lim Kim
Journal:  Ther Apher Dial       Date:  2007-02       Impact factor: 1.762

9.  Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose.

Authors:  Krzysztof Ksiazek; Andrzej Breborowicz; Achim Jörres; Janusz Witowski
Journal:  Free Radic Biol Med       Date:  2006-12-09       Impact factor: 7.376

10.  3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.

Authors:  Marina Penélope Catalan; Beatriz Santamaría; Ana Reyero; Arturo Ortiz; Jesús Egido; Alberto Ortiz
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

View more
  5 in total

1.  Aminoguanidine reduces diabetes-associated cardiac fibrosis.

Authors:  Fernando Magdaleno; Chuck Christopher Blajszczak; Claudia Lisette Charles-Niño; Alma Marlene Guadrón-Llanos; Alan Omar Vázquez-Álvarez; Alejandra Guillermina Miranda-Díaz; Natalia Nieto; María Cristina Islas-Carbajal; Ana Rosa Rincón-Sánchez
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

2.  Targeting lysyl oxidase reduces peritoneal fibrosis.

Authors:  Christopher R Harlow; Xuan Wu; Marielle van Deemter; Fiona Gardiner; Craig Poland; Rebecca Green; Sana Sarvi; Pamela Brown; Karl E Kadler; Yinhui Lu; J Ian Mason; Hilary O D Critchley; Stephen G Hillier
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

3.  Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca2+ and Na+ Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathways.

Authors:  Felipe Simon; Pablo Tapia; Ricardo Armisen; Cesar Echeverria; Sebastian Gatica; Alejandro Vallejos; Alejandro Pacheco; Maria E Sanhueza; Miriam Alvo; Erico Segovia; Rubén Torres
Journal:  Front Physiol       Date:  2017-06-13       Impact factor: 4.566

Review 4.  Nano-sized carriers in gene therapy for peritoneal fibrosis in vivo.

Authors:  Yusuke Igarashi; Taro Hoshino; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Nano Rev Exp       Date:  2017-06-15

5.  Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells.

Authors:  Taito Miyake; Norihiko Sakai; Akira Tamai; Koichi Sato; Yasutaka Kamikawa; Taro Miyagawa; Hisayuki Ogura; Yuta Yamamura; Megumi Oshima; Shiori Nakagawa; Akihiro Sagara; Yasuyuki Shinozaki; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Yasunori Iwata; Miho Shimizu; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.